Loading…

Combination of Imvotamab and Loncastuximab Tesirine Shows Enhanced Anti‐Tumor Activity in a Preclinical Model of Non‐Hodgkin’s Lymphoma

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2023-06, Vol.41 (S2), p.552-553
Main Authors:	Logronio, K. A., Joglekar, M., Oyasu, M., Yakkundi, P., Leabman, M. K., Hernandez, G., Manley, T., Sinclair, A. M., Carroll, S. F., Candia, A., Keyt, B. A., Kotturi, M. F.
Format:	Article
Language:	English
Subjects:	Lymphoma
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!